Resmed Sells MatrixCare to Frazier Healthcare to Focus on Connected Care

Corporate Action
โดย Zacks Investment Research·Read original
Summary · why it matters

Resmed has agreed to sell its MatrixCare business to private equity firm Frazier Healthcare Partners, sharpening its focus on sleep health, breathing health, and connected home-based care. The transaction covers the entire MatrixCare business, including Healthcare First, Citus, and its home health and hospice software solutions, which serve more than 15,000 providers, but excludes Resmed's other healthcare software businesses Brightree and MEDIFOX DAN. The deal is expected to close in the first quarter of fiscal 2027, subject to regulatory approvals and customary closing conditions. Resmed stated that MatrixCare will continue operating as part of the company until closing with no disruption to customer service. The divestiture is intended to enhance capital allocation flexibility and allow Resmed to accelerate investments in AI-powered digital health and cloud-connected medical devices.

Impact on stocks 4

Biotech & Genomic Medicine · 3 stocks
Cloud & Digital Infrastructure · 1 stocks
ResMed Inc
RMD
▲ PositiveCapitalrelevance

Resmed sells MatrixCare to enhance capital allocation flexibility and focus on core connected care, which is a strategic divestiture.

Off-coverage companies 2

Frazier Healthcare PartnersPrivate± Mixed
relevance

MatrixCarePrivate± Mixed
relevance